肺黏膜相关淋巴组织淋巴瘤临床特征及预后分析

R733.4; 目的:探讨肺黏膜相关淋巴组织(mucosa-associated lymphoid tissue,MALT)淋巴瘤的临床特征及预后.方法:回顾性分析2013年1月至2020年6月复旦大学附属中山医院血液科收治的77例初发肺M A L T淋巴瘤患者的临床资料.结果:77例肺MALT淋巴瘤患者,男性32例(41.6%),女性45例(58.4%),中位发病年龄为59(24~85)岁.肺占位患者32例(41.6%),症状起病患者45例(58.4%),主要表现为肺部非特异性症状.AnnArbor分期为Ⅰ期14例(18.2%)、Ⅱ期3例(3.9%)、Ⅲ期1例(1.3%)、Ⅳ期59例(76....

Full description

Saved in:
Bibliographic Details
Published in中国临床医学 Vol. 28; no. 5; pp. 765 - 770
Main Authors 施淼颉, 魏征, 庄静丽, 王伟光, 王志梅, 柯杨, 程志祥, 袁玲, 季丽莉, 承璐雅, 刘澎
Format Journal Article
LanguageChinese
Published 复旦大学附属中山医院血液科,上海 200032 01.10.2021
Subjects
Online AccessGet full text
ISSN1008-6358
DOI10.12025/j.issn.1008-6358.2021.20210713

Cover

Abstract R733.4; 目的:探讨肺黏膜相关淋巴组织(mucosa-associated lymphoid tissue,MALT)淋巴瘤的临床特征及预后.方法:回顾性分析2013年1月至2020年6月复旦大学附属中山医院血液科收治的77例初发肺M A L T淋巴瘤患者的临床资料.结果:77例肺MALT淋巴瘤患者,男性32例(41.6%),女性45例(58.4%),中位发病年龄为59(24~85)岁.肺占位患者32例(41.6%),症状起病患者45例(58.4%),主要表现为肺部非特异性症状.AnnArbor分期为Ⅰ期14例(18.2%)、Ⅱ期3例(3.9%)、Ⅲ期1例(1.3%)、Ⅳ期59例(76.6%).15例无治疗指征而观察随访,19例手术治疗,3例接受抗炎治疗,43例接受化疗治疗(化疗方案主要包括RC、R-CHOP、R2、BR等),2例患者拒绝治疗.一线治疗后最佳疗效,25例(32.5%)完全缓解,31例(40.2%)部分缓解,16例(20.8%)疾病稳定,2例(2.6%)病情进展,总体反应率72.7%.结束治疗后继续随访过程中,14例患者复发进展.随访截止时间为2020年11月20日,中位随访时间为35.3(5.5~96.0)个月,中位OS及PFS均未达到,5年OS率和PFS率分别为95.1% 和73.2%.AnnArbor分期Ⅰ/Ⅱ期和Ⅲ/Ⅳ期患者的OS和PFS差异无统计学意义(P=0.455、0.834).接受局部治疗(主要是手术)与接受全身治疗(化疗)的患者相比,接受化疗组患者远期PFS更好(P=0.004).对于Ⅰ/Ⅱ期患者单独进行了不同治疗方案的PFS分析,趋势同整体人群相当.53例患者可计算POD24,7例患者POD24阳性,POD24对预后差异有统计学意义(P=0.046).结论:肺MALT淋巴瘤总体预后较好,不同疾病分期OS、PFS差异无统计学意义.接受全身化疗可能为患者带来更长的获益,而单纯手术治疗可能与较差的PFS相关.POD24阳性与肺MALT淋巴瘤不良预后相关.
AbstractList R733.4; 目的:探讨肺黏膜相关淋巴组织(mucosa-associated lymphoid tissue,MALT)淋巴瘤的临床特征及预后.方法:回顾性分析2013年1月至2020年6月复旦大学附属中山医院血液科收治的77例初发肺M A L T淋巴瘤患者的临床资料.结果:77例肺MALT淋巴瘤患者,男性32例(41.6%),女性45例(58.4%),中位发病年龄为59(24~85)岁.肺占位患者32例(41.6%),症状起病患者45例(58.4%),主要表现为肺部非特异性症状.AnnArbor分期为Ⅰ期14例(18.2%)、Ⅱ期3例(3.9%)、Ⅲ期1例(1.3%)、Ⅳ期59例(76.6%).15例无治疗指征而观察随访,19例手术治疗,3例接受抗炎治疗,43例接受化疗治疗(化疗方案主要包括RC、R-CHOP、R2、BR等),2例患者拒绝治疗.一线治疗后最佳疗效,25例(32.5%)完全缓解,31例(40.2%)部分缓解,16例(20.8%)疾病稳定,2例(2.6%)病情进展,总体反应率72.7%.结束治疗后继续随访过程中,14例患者复发进展.随访截止时间为2020年11月20日,中位随访时间为35.3(5.5~96.0)个月,中位OS及PFS均未达到,5年OS率和PFS率分别为95.1% 和73.2%.AnnArbor分期Ⅰ/Ⅱ期和Ⅲ/Ⅳ期患者的OS和PFS差异无统计学意义(P=0.455、0.834).接受局部治疗(主要是手术)与接受全身治疗(化疗)的患者相比,接受化疗组患者远期PFS更好(P=0.004).对于Ⅰ/Ⅱ期患者单独进行了不同治疗方案的PFS分析,趋势同整体人群相当.53例患者可计算POD24,7例患者POD24阳性,POD24对预后差异有统计学意义(P=0.046).结论:肺MALT淋巴瘤总体预后较好,不同疾病分期OS、PFS差异无统计学意义.接受全身化疗可能为患者带来更长的获益,而单纯手术治疗可能与较差的PFS相关.POD24阳性与肺MALT淋巴瘤不良预后相关.
Author 施淼颉
魏征
袁玲
王志梅
承璐雅
柯杨
刘澎
庄静丽
王伟光
季丽莉
程志祥
AuthorAffiliation 复旦大学附属中山医院血液科,上海 200032
AuthorAffiliation_xml – name: 复旦大学附属中山医院血液科,上海 200032
Author_FL WEI Zheng
LIU Peng
SHI Miao-jie
JI Li-li
CHENG Zhi-xiang
KE Yang
YUAN Ling
WANG Zhi-mei
ZHUANG Jing-li
WANG Wei-guang
CHENG Lu-ya
Author_FL_xml – sequence: 1
  fullname: SHI Miao-jie
– sequence: 2
  fullname: WEI Zheng
– sequence: 3
  fullname: ZHUANG Jing-li
– sequence: 4
  fullname: WANG Wei-guang
– sequence: 5
  fullname: WANG Zhi-mei
– sequence: 6
  fullname: KE Yang
– sequence: 7
  fullname: CHENG Zhi-xiang
– sequence: 8
  fullname: YUAN Ling
– sequence: 9
  fullname: JI Li-li
– sequence: 10
  fullname: CHENG Lu-ya
– sequence: 11
  fullname: LIU Peng
Author_xml – sequence: 1
  fullname: 施淼颉
– sequence: 2
  fullname: 魏征
– sequence: 3
  fullname: 庄静丽
– sequence: 4
  fullname: 王伟光
– sequence: 5
  fullname: 王志梅
– sequence: 6
  fullname: 柯杨
– sequence: 7
  fullname: 程志祥
– sequence: 8
  fullname: 袁玲
– sequence: 9
  fullname: 季丽莉
– sequence: 10
  fullname: 承璐雅
– sequence: 11
  fullname: 刘澎
BookMark eNo9T09LAkEcnYNBZn4OT7v9fjPtzuwpQvoHQpc6y-zurCgyQkP051aYlUJ6DIoO0TdI0Fzo0zSufovEpMt7j_fgPd4GyemWVoSUEFykQL2thls3RrsIIByfecJduLgE4MhyJP-frJOiMfUQAMEDRiFPdma3k3nan3Ves5exvfucjnp2NMzSdpber_Tzx894aCfd7PHLft_Yfnf-3raDJ_vQmb4NNslaIptGFVdcIKf7eyflQ6dyfHBU3q04BoFyhysVUp_CggUP4pCpmEoeeVIEmPiIQjCqPCYkqCiO_CBSCsMk5ojbHH0mWIGU_novpE6krlUbrfMzvVisXtea0dXl8q0HwNkvjdVmXA
ClassificationCodes R733.4
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.12025/j.issn.1008-6358.2021.20210713
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Clinical characteristics and prognosis of pulmonary mucosa-associated lymphoid tissue lymphoma
EndPage 770
ExternalDocumentID zglcyx202105007
GroupedDBID 2B.
4A8
92I
93N
ALMA_UNASSIGNED_HOLDINGS
CDYEO
PSX
TCJ
ID FETCH-LOGICAL-s1027-7eeb26207ee879db3ed2a7c5a891f6118832e538a0ecdc69cee1bfd7114716383
ISSN 1008-6358
IngestDate Thu May 29 04:08:22 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 5
Keywords 肺黏膜相关淋巴组织淋巴瘤;临床特征;手术;化疗;POD24
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1027-7eeb26207ee879db3ed2a7c5a891f6118832e538a0ecdc69cee1bfd7114716383
PageCount 6
ParticipantIDs wanfang_journals_zglcyx202105007
PublicationCentury 2000
PublicationDate 2021-10-01
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-01
  day: 01
PublicationDecade 2020
PublicationTitle 中国临床医学
PublicationTitle_FL Chinese Journal of Clinical Medicine
PublicationYear 2021
Publisher 复旦大学附属中山医院血液科,上海 200032
Publisher_xml – name: 复旦大学附属中山医院血液科,上海 200032
SSID ssib001050320
ssib006562945
ssib036441625
ssib001103563
ssib002262996
ssib008144075
ssib051368386
Score 2.2838554
Snippet R733.4; 目的:探讨肺黏膜相关淋巴组织(mucosa-associated lymphoid tissue,MALT)淋巴瘤的临床特征及预后.方法:回顾性分析2013年1月至2020年6月复旦大学附属中山医院血液科...
SourceID wanfang
SourceType Aggregation Database
StartPage 765
Title 肺黏膜相关淋巴组织淋巴瘤临床特征及预后分析
URI https://d.wanfangdata.com.cn/periodical/zglcyx202105007
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ
  issn: 1008-6358
  databaseCode: DOA
  dateStart: 20160101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.doaj.org/
  omitProxy: true
  ssIdentifier: ssib006562945
  providerName: Directory of Open Access Journals
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEB5iBPEiiopv9mDjadd59aNOMrM7SxD0lEBuYV4bD7JCsgHNTYlRI5gcBcWD5B8YSEzAX-Nkk39hVU_vzKDBFyyzTXVNPXemvu7tmbas277MIeVJjMOSlLex3mZtyGjgKkD4qZdnA73ZxIOHYmbOvz_P56dObTdWLa2Mkk66euJzJf-TVaRhXukp2X_IbCUUCdjG_OIRM4zHv8oxixRTLgsDFgELQ6b6miIYdFkkGYQsVCziTHEWeiwSLJRMhUTBRugTD51VNeTJPKBYgA2fpBGFk0YVUJdCvaApEWJSrauvu4AFrpbMGdhMRbpL24YqIGLl7p0TWGyEBz3Nj2b3TlKHErpkJzaQM6jmFLVIoU_S5ofdiX6oWYDOoQAZW-ueUr5PLNBjABPVvZpFkgcUFZ-EQ98E1cg3kyauUy2_K3_m2lDE6toukGixoQSy8kFrBROp0KHQNGOBlNBpeK6Z0TNMc-DQKhXyGD8u2YhiAQtT10igkGEXJZJeHGk3Z3jpZUttRIGqWaJc1bgUeaPeyHKjDQNdZLkHyy9VESPAdVkkDZ1KQ4ciow80VVEDgmqZ5uri4_TZU83A9SsbTrtSCLcxcVFOKnD0oAHCHdvjogkSBWKeGvTiCMKFxn_ZitYX1CDWI4Qu6irDHU8oT2_ZWll-xroz8evu773Sz-INB_FwsQEbZ89b58x4rxWUF-8Fa2r10UXr3tGL_eODzaP1j-MPe8XLL4e7b4vdnfHB2vjglWm_3_6-t1Psb4zffC2-PS82N44_rxVb74rX64efti5Zc_1otjvTNjuZtJcRwMu2zPOEdn7AbyUhS_Ae6MYy5bECZyBwjI91NUfoEdt5mqUCELk6ySCTjoPYESukd9maHj4Z5leslo8iIM1ypUTsSy-BzE8yR6V2bNuDxFZXrZZxeMHcqZYXfsrjtT-zXLfO1pfNDWt6tLSS30T0PUpu6eT_AGdYoWI
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%82%BA%E9%BB%8F%E8%86%9C%E7%9B%B8%E5%85%B3%E6%B7%8B%E5%B7%B4%E7%BB%84%E7%BB%87%E6%B7%8B%E5%B7%B4%E7%98%A4%E4%B8%B4%E5%BA%8A%E7%89%B9%E5%BE%81%E5%8F%8A%E9%A2%84%E5%90%8E%E5%88%86%E6%9E%90&rft.jtitle=%E4%B8%AD%E5%9B%BD%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6&rft.au=%E6%96%BD%E6%B7%BC%E9%A2%89&rft.au=%E9%AD%8F%E5%BE%81&rft.au=%E5%BA%84%E9%9D%99%E4%B8%BD&rft.au=%E7%8E%8B%E4%BC%9F%E5%85%89&rft.date=2021-10-01&rft.pub=%E5%A4%8D%E6%97%A6%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E4%B8%AD%E5%B1%B1%E5%8C%BB%E9%99%A2%E8%A1%80%E6%B6%B2%E7%A7%91%2C%E4%B8%8A%E6%B5%B7+200032&rft.issn=1008-6358&rft.volume=28&rft.issue=5&rft.spage=765&rft.epage=770&rft_id=info:doi/10.12025%2Fj.issn.1008-6358.2021.20210713&rft.externalDocID=zglcyx202105007
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzglcyx%2Fzglcyx.jpg